Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride improved both hair loss and acne in two young men.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.

Cyproterone acetate with ethynyl estradiol significantly improved acne and seborrhea in women, but was less effective for hair loss and excessive hair growth.

These drugs cause hair growth without affecting testosterone or adrenal hormones.

Antiandrogens might help prevent or treat COVID-19 by blocking the virus's entry into cells.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

Certain hormone treatments can improve acne and related conditions in women.

AMT may cause hair loss and changing dWAT activity could help treat it.

The study created a model to help design new inhibitors for steroidal 5α-reductase enzymes.

Women with androgenetic alopecia (AGA) are more insulin resistant than healthy women, with various insulin sensitivity indices being higher in the AGA group. An oral glucose tolerance test is suggested for women with AGA.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Some patients may experience lasting sexual dysfunction, depression, and other side effects from 5α-reductase inhibitor therapy.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Certain fats in the blood are linked to an increased risk of male pattern baldness.

Growth hormone therapy boosts androgen effects on skin in men.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.

Anabolic steroid misuse is a major health issue causing severe health problems and requires better awareness and monitoring.

Androgenetic alopecia is a common genetic and hormonal hair loss affecting many men and women.

The conclusion is that more hair loss (androgenetic alopecia) is linked to larger prostate size, suggesting hair loss could be an early sign of benign prostatic hyperplasia.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

More men have Androgenic Alopecia than women, it's often inherited, and stress can contribute to it.

5α-reductase inhibitors may worsen sexual drive and spontaneous erections but don't worsen existing erectile or ejaculatory problems.

The hHa7 gene is regulated by androgens in certain body hair, not scalp hair.

Various treatments effectively manage androgenetic alopecia.